摘要
尽管报道称纤维性海绵体炎(PD)的患病率在男性中为3-9%,但是真正的患病率由于漏报可能会更高。许多具有不同程度治疗成功率的治疗方法被描述了。本文,我们对目前关于所有的药物疗法(空腔,病灶内,电离子渗疗法和局部的)的文献和PD的微创治疗(真空,驱动轮加载装置,冲击波疗法,和放射疗法)进行了综述和总结。此外,我们讨论了PD的仍然停留在临床前研究的新兴疗法,包括干细胞治疗。
关键词: 药物疗法,纤维性海绵体炎,冲击波疗法,干细胞疗法,胶原酶
Current Drug Targets
Title:Management of Peyronie's Disease after Collagenase (Xiaflex:®)
Volume: 16 Issue: 5
Author(s): Amjad Alwaal, Ahmed Aly Hussein, Uwais B. Zaid and Tom F. Lue
Affiliation:
关键词: 药物疗法,纤维性海绵体炎,冲击波疗法,干细胞疗法,胶原酶
摘要: Although the prevalence of Peyronie’s disease (PD) is reported to be 3-9% in men, the true prevalence is likely higher due to under-reporting. Many treatment modalities have been described for PD with varying degrees of success. In this article, we review and summarize the current literature pertaining to all pharmacotherapies (oral, intralesional, iontophoresis, and topical) and minimally invasive treatments available for PD (vacuum, traction device, shock wave therapy, and radiation treatment). Additionally, we discuss emerging therapies for PD that are still in pre-clinical development, including stem cell therapy.
Export Options
About this article
Cite this article as:
Amjad Alwaal, Ahmed Aly Hussein, Uwais B. Zaid and Tom F. Lue , Management of Peyronie's Disease after Collagenase (Xiaflex:®), Current Drug Targets 2015; 16 (5) . https://dx.doi.org/10.2174/1389450115666141114163128
DOI https://dx.doi.org/10.2174/1389450115666141114163128 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Books

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Exosomes: The Messengers of Health and Disease
Current Neuropharmacology Nociceptin/Orphanin FQ Peptide Receptor as a Therapeutic Target for Obesity
Mini-Reviews in Medicinal Chemistry Role of Matrix Metalloproteinases in Animal Models of Ischemic Stroke
Current Vascular Pharmacology Relationship Between Proinsulin Level and Cardiovascular Risk Factors Clustering: An Epidemiological Study
Vascular Disease Prevention (Discontinued) A Review on the Sex Differences in Organ and System Pathology with Alcohol Drinking
Current Drug Abuse Reviews SDH Genes: From Glomic Tumours to Pheochromocytomas
Current Hypertension Reviews Towards the Design of Social Media to Promote Physical Activity
Recent Advances in Communications and Networking Technology (Discontinued) The Emerging Role of Arginase in Endothelial Dysfunction in Diabetes
Current Vascular Pharmacology The Role of Infection in Carotid Plaque Pathogenesis and Stability: The Clinical Evidence
Current Vascular Pharmacology Developments of Anticoagulants and New Agents with Anti-Coagulant Effects in Deep Vein Thrombosis
Mini-Reviews in Medicinal Chemistry Endothelial Therapy of Atherosclerosis and its Risk Factors
Current Vascular Pharmacology Prognostic Role of Sub-Clinical Hypothyroidism in Chronic Heart Failure Outpatients
Current Pharmaceutical Design Editorial (Thematic Issue: Antithrombotic Therapy: Current and Future Clinical Use)
Current Vascular Pharmacology Synthesis and Evaluation of Compounds Containing 4-arylpiperazinyl Moieties Linked to a 2-(pyridin-3-yl)-1H-benzimidazole as p38 MAP Kinase Inhibitors
Letters in Drug Design & Discovery TGR5 as a Therapeutic Target for Treating Obesity
Current Topics in Medicinal Chemistry Αlpha-2 Adrenergic and Opioids Receptors Participation in Mice Gastroprotection of Abelmoschus esculentus Lectin
Current Pharmaceutical Design Angiotensin-Converting Enzyme - New Insights into Structure, Biological Significance and Prospects for Domain-Selective Inhibitors
Current Enzyme Inhibition Editorial [Hot Topic: Modifying Cardiovascular Risk Factors: Epidemiology and Characteristics of Hypertension-Related Disorders (Executive Guest Editor: Aurelio Leone)]
Current Pharmaceutical Design Insulin Resistance in the Early Stages of Renal Failure: Implications for Cardiovascular Risk
Current Diabetes Reviews In the Search of the Vulnerable Plaque: Current Diagnostic Techniques and Future Directions
Vascular Disease Prevention (Discontinued)